Given the data we have uncovered, as well as TNFα/IL-1β's therapeutic relevance in autoimmune diseases and cancer, it would be beneficial to examine miR-708's ability to reduce autoimmune-related inflammation and oncogenesis. Here, IL1B is linked to cancer.